Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Bath & Body Works, Inc. (NYSE:BBWI - Get Rating)'s stock price hit a new 52-week low during trading on Tuesday after Citigroup lowered their price target on the stock from $87.00 to $54.00. Citigroup currently has a buy rating on the stock. Bath & Body Works traded as low as $36.05 and last traded at $36.19, with a volume of 79978 shares changing hands. The stock had previously closed at $38.53.

BBWI has been the subject of a number of other research reports. Deutsche Bank Aktiengesellschaft cut their price objective on Bath & Body Works from $78.00 to $61.00 in a research report on Thursday, May 19th. Telsey Advisory Group reduced their target price on Bath & Body Works from $70.00 to $60.00 and set an "outperform" rating for the company in a report on Thursday, May 19th. Barclays reduced their target price on Bath & Body Works from $53.00 to $40.00 and set an "equal weight" rating for the company in a report on Friday. Wells Fargo & Company reduced their target price on Bath & Body Works from $85.00 to $70.00 and set an "overweight" rating for the company in a report on Tuesday, April 5th. Finally, Morgan Stanley reduced their target price on Bath & Body Works from $95.00 to $64.00 and set an "overweight" rating for the company in a report on Friday. Three analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $66.20.

In other Bath & Body Works news, CFO Wendy C. Arlin sold 6,000 shares of the stock in a transaction on Tuesday, April 19th. The shares were sold at an average price of $55.00, for a total transaction of $330,000.00. Following the transaction, the chief financial officer now directly owns 98,888 shares of the company's stock, valued at $5,438,840. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.37% of the company's stock.

Institutional investors have recently bought and sold shares of the business. Baader Bank INC bought a new stake in Bath & Body Works during the first quarter valued at about $1,327,000. Worldquant Millennium Advisors LLC bought a new stake in Bath & Body Works during the first quarter valued at about $18,662,000. Walleye Capital LLC bought a new stake in Bath & Body Works during the first quarter valued at about $272,000. Wealthfront Advisers LLC boosted its holdings in Bath & Body Works by 2.7% during the first quarter. Wealthfront Advisers LLC now owns 132,239 shares of the company's stock valued at $6,321,000 after acquiring an additional 3,491 shares during the period. Finally, KB Financial Partners LLC boosted its holdings in Bath & Body Works by 30.5% during the first quarter. KB Financial Partners LLC now owns 9,370 shares of the company's stock valued at $448,000 after acquiring an additional 2,191 shares during the period. 97.11% of the stock is currently owned by hedge funds and other institutional investors.

The stock's fifty day simple moving average is $49.82 and its 200-day simple moving average is $58.28. The company has a market capitalization of $8.66 billion, a P/E ratio of 8.39, a PEG ratio of 1.11 and a beta of 1.56.

Bath & Body Works (NYSE:BBWI - Get Rating) last released its earnings results on Wednesday, May 18th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.11. Bath & Body Works had a net margin of 15.41% and a negative return on equity of 83.19%. Equities analysts anticipate that Bath & Body Works, Inc. will post 3.9 EPS for the current year.

Bath & Body Works Company Profile (NYSE:BBWI)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured ArticlesGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)Veeva Systems: Increasing NDR and Other WinsFundamental Strength Makes Williams-Sonoma One for Your Recovery Watchlist Institutions Buy The Dip In Petco Health and Wellness Company Autozone Edges Past Advanced Auto Parts In Q1 2022CrowdStrike: A Cybersecurity Unicorn

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Each market day you'll get a one-minute market summary to help you invest wisely.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.